Arrakis Therapeutics vs Avidity Biosciences
Arrakis Therapeutics vs Avidity Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arrakis Therapeutics is on 46/100 and Avidity Biosciences on 53/100.
Where each one leads
Arrakis Therapeutics
Leads on none of the measures we hold for both companies.
Avidity Biosciences
- our overall score: 53/100 against 46/100
- domain rating: 46/100 against 29/100
- headcount: 445 against 52
- LinkedIn following: 37,705 against 12,956
At a glance
| Measure | Arrakis Therapeutics | Avidity Biosciences |
|---|---|---|
| What it is | Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. |
| Category | Biotech, Drug Discovery, RNA Therapeutics, Small Molecule Drugs | Biotech, Drug Discovery, Genomics, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2014 | 2013 |
| Headquarters | Waltham, United States | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Arrakis Therapeutics | Avidity Biosciences |
|---|---|---|
| Employees | 52 | 445 |
| Total funding | Not published | $495M |
| Latest round | Not published | IPO |
| LinkedIn followers | 12,956 | 37,705 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arrakis Therapeutics | Avidity Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 53/100 |
| Traction | 17/100 | 60/100 |
| Search visibility | 34/100 | 22/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arrakis Therapeutics | Avidity Biosciences |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | Arrakis Therapeutics | Avidity Biosciences |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 2 negative across 4 threads | Not published |
“Pharmaunternehmen - Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics, Der Pharmakonzern Roche hat sich auf eine Lizenzvereinbarung mit dem US-Biotechunternehmen Arrakis Therapeutics geeinigt..”r/chpresseschau
Arrakis Therapeutics vs Avidity Biosciences: common questions
Which is better, Arrakis Therapeutics or Avidity Biosciences?
On our 0-100 score Avidity Biosciences rates higher (53/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Arrakis Therapeutics and Avidity Biosciences compare on the numbers?
Avidity Biosciences leads on our overall score (53/100 against 46/100), domain rating (46/100 against 29/100), headcount (445 against 52), LinkedIn following (37,705 against 12,956).
What do real users say about Arrakis Therapeutics and Avidity Biosciences?
Arrakis Therapeutics: 2 positive and 2 negative mentions across 4 Reddit threads we track, mostly in r/chpresseschau.
Read the full Arrakis Therapeutics review and pricing or the Avidity Biosciences review and pricing. You can also browse other Arrakis Therapeutics alternatives we track.